MENU
LSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LakeShore Biopharma (LSB) Ownership - Who owns LakeShore Biopharma?

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
49.42M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
7.41 USD as % of share price

Fundamentals

LSB
Capitalization
49.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.41%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
0.61
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
1.41
Current Revenue Per Employee
125250.27
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
81.92
Revenue To Assets
N/A
Shares Held By Institutions
3.64M
Shares Outstanding - Current
19.1M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-49.315
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details